Evidence mapPaperPMID 40650727Full record

ArticleEndocrine2025

Alterations of the pancreas in type 1 diabetes - from prior to diagnosis to long-standing disease.

Nathalia Guarienti Missima, Henrik Hill, Casian-Simon Aioanei, Per Liss, Daniel Espes

Abstract read
In one paragraph

Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathalia Guarienti MissimaScience for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Henrik HillDepartment of Women´s and Children´s Health, Uppsala University, Uppsala, Sweden.
Casian-Simon AioaneiScience for Life Laboratory, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Per LissDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Daniel EspesScience for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. daniel.espes@scilifelab.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn type 1 diabetes (T1D), the loss of insulin-producing beta-cells is the hallmark pathophysiological alteration. However, volumetric and functional abnormalities of the exocrine pancreas are also observed. These changes may result from the loss of insulin's anabolic effects or reflect an underexplored aspect of T1D. Imaging techniques have enabled a better characterization of pancreatic morphology throughout T1D progression. This study examines exocrine pancreatic alterations at various stages of T1D using CT scans, including assessments conducted prior to diagnosis.

methodsThe study utilized retrospective abdominal CT scans and clinical data collected from Uppsala University Hospital, including 150 T1D subjects, with 15 examined before diagnosis, and 61 age- and gender-matched non-diabetic controls. Volume segmentation and 3D reconstruction assessed the exocrine pancreas, and pancreas volume index (PVI) calculations were standardized using body weight, BMI, and body surface area (BSA). Descriptive and laboratory data were obtained from electronic medical records.

resultsPancreas volume was significantly reduced in T1D patients. The reduction was more pronounced in patients diagnosed before the age of 20. No significant volume difference was noted in patients before their T1D diagnosis compared to controls, however, a reduction was observed post-diagnosis. Pancreas volume correlated negatively with disease duration and HbA1c levels and correlated positively with body surface area and plasma amylase levels.

conclusionPancreas volume reduction is a consistent feature in T1D, correlating with both disease duration and markers of metabolic control. These findings support the potential of using imaging techniques as a non-invasive method for monitoring T1D progression.

Indexed as

Diabetes Mellitus, Type 1PancreasAdolescentAdultChildDisease ProgressionFemaleHumansMaleMiddle AgedOrgan SizeRetrospective StudiesTomography, X-Ray ComputedYoung AdultExocrine atrophyExocrine pancreasImagingType 1 diabetesVolume

Identifiers

PMID40650727
PMCPMC12464134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.